LON:AGL - ANGLE Share Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding ANGLE plc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 60.50 0.00 (0.00 %) (As of 12/12/2019 01:26 PM ET) Add Compare Today's Range 60.21Now: GBX 60.50▼ 6150-Day Range 60MA: GBX 67.50▼ 79.5052-Week Range 38Now: GBX 60.50▼ 85Volume51,891 shsAverage Volume106,228 shsMarket Capitalization£104.52 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartInsider TradesHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products. It develops and commercializes Parsortix cell separation system, which captures and harvests rare circulating tumor cells in cancer patient blood; and Ziplex multiplex analysis system that is used with the ovarian cancer clinical application and others. The company was founded in 2004 and is based in Guildford, the United Kingdom. Industry, Sector and Symbol Stock Exchange LON Industry Medical Laboratories & Research Sub-IndustryN/A SectorMedical Current SymbolLON:AGL Previous Symbol CUSIPN/A CIKN/A Webhttp://www.angleplc.com/ Phone+44-1483-685830Debt Debt-to-Equity RatioN/A Current Ratio4.03 Quick Ratio3.64Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales£678,000.00 Price / Sales154.15 Cash FlowGBX 7.64 per share Price / Cash Flow7.92 Book ValueGBX 13.50 per share Price / Book4.48Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees43 Outstanding Shares172,755,008Market Cap£104.52 million Next Earnings Date1/29/2020 (Estimated) OptionableNot Optionable Receive AGL News and Ratings via Email Sign-up to receive the latest news and ratings for AGL and its competitors with MarketBeat's FREE daily newsletter. LSE:AGL Rates by TradingView ANGLE (LON:AGL) Frequently Asked Questions What is ANGLE's stock symbol? ANGLE trades on the London Stock Exchange (LON) under the ticker symbol "AGL." When is ANGLE's next earnings date? ANGLE is scheduled to release their next quarterly earnings announcement on Wednesday, January 29th 2020. View Earnings Estimates for ANGLE. Has ANGLE been receiving favorable news coverage? Media headlines about AGL stock have trended very negative this week, InfoTrie Sentiment reports. The research group scores the sentiment of press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. ANGLE earned a news sentiment score of -3.1 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for ANGLE. Who are some of ANGLE's key competitors? Some companies that are related to ANGLE include VolitionRX (VNRX), Spectral Medical (EDT), Proteome Sciences (PRM), DiaSorin (DIA), Polarityte (COOL) and Premaitha Health (NIPT). What other stocks do shareholders of ANGLE own? Based on aggregate information from My MarketBeat watchlists, some companies that other ANGLE investors own include Yamana Gold (YRI), Asiamet Resources (ARS), Dekeloil Public (DKL), Polo Resources (POL), Eldorado Gold (ELD), Silvercorp Metals (SVM), Nippon Dragon Resources (NIP), Ariana Resources (AAU), African Potash (AFPO) and Advanced Oncotherapy (AVO). Who are ANGLE's key executives? ANGLE's management team includes the folowing people: Mr. Andrew David William Newland, Founder, CEO & Exec. Director (Age 57)Mr. Ian Francis Griffiths, CFO, Fin. Director, Company Sec. & Exec. Director (Age 54)Dr. Daniel J. O'Shannessy, Chief Scientific OfficerMr. Paul Smith, VP & Chief Exec. Officer of ANGLE Biosciences IncMr. Martin Cooke, Director of Manufacturing & Regulatory Affairs (Age 50) How do I buy shares of ANGLE? Shares of AGL and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is ANGLE's stock price today? One share of AGL stock can currently be purchased for approximately GBX 60.50. How big of a company is ANGLE? ANGLE has a market capitalization of £104.52 million and generates £678,000.00 in revenue each year. ANGLE employs 43 workers across the globe.View Additional Information About ANGLE. What is ANGLE's official website? The official website for ANGLE is http://www.angleplc.com/. How can I contact ANGLE? ANGLE's mailing address is The Surrey Research Park 3 Frederick Sanger Road, GUILDFORD, GU2 7YD, United Kingdom. The company can be reached via phone at +44-1483-685830. MarketBeat Community Rating for ANGLE (LON AGL)Community Ranking: 2.1 out of 5 ( )Outperform Votes: 155 (Vote Outperform)Underperform Votes: 207 (Vote Underperform)Total Votes: 362MarketBeat's community ratings are surveys of what our community members think about ANGLE and other stocks. Vote "Outperform" if you believe AGL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AGL will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/12/2019 by MarketBeat.com StaffFeatured Article: 12b-1 Fees